SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-203755
Filing Date
2024-08-20
Accepted
2024-08-20 17:24:59
Documents
19
Period of Report
2024-08-19
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d846843d8k.htm   iXBRL 8-K 38859
2 EX-1.1 d846843dex11.htm EX-1.1 217069
3 EX-4.1 d846843dex41.htm EX-4.1 77202
4 EX-5.1 d846843dex51.htm EX-5.1 10192
5 EX-99.1 d846843dex991.htm EX-99.1 10291
6 EX-99.2 d846843dex992.htm EX-99.2 11208
10 GRAPHIC g846843g0820102031754.jpg GRAPHIC 3135
  Complete submission text file 0001193125-24-203755.txt   584777

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA kymr-20240819.xsd EX-101.SCH 2853
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE kymr-20240819_lab.xml EX-101.LAB 17994
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kymr-20240819_pre.xml EX-101.PRE 11263
21 EXTRACTED XBRL INSTANCE DOCUMENT d846843d8k_htm.xml XML 3646
Mailing Address 500 NORTH BEACON STREET, 4TH FLOOR WATERTOWN MA 02472
Business Address 500 NORTH BEACON STREET, 4TH FLOOR WATERTOWN MA 02472 857-285-5314
Kymera Therapeutics, Inc. (Filer) CIK: 0001815442 (see all company filings)

IRS No.: 812992166 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39460 | Film No.: 241226349
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)